Detalles de la búsqueda
1.
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia.
Blood
; 131(24): 2661-2669, 2018 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29724899
2.
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study.
Lancet Oncol
; 19(5): 649-659, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29650362
3.
Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer.
Breast Cancer Res Treat
; 130(3): 825-31, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21976055
4.
Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study.
Breast Cancer Res Treat
; 125(1): 115-20, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20945091
5.
Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.
Clin Breast Cancer
; 7(11): 850-6, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18269774
6.
Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer.
Clin Breast Cancer
; 13(4): 239-246.e1, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23829890
7.
Phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: final analysis of overall survival.
Clin Breast Cancer
; 12(5): 313-21, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22728026
8.
A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma.
Cancer
; 116(1): 155-63, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19877111
9.
Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer.
Clin Breast Cancer
; 10(4): 281-7, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20705560
10.
Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer.
J Clin Oncol
; 27(22): 3611-9, 2009 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19470941
Resultados
1 -
10
de 10
1
Próxima >
>>